EMU, Pfizer experts to discuss ethical issues surrounding Alzheimer's disease
YPSILANTI - The Gerontology Program at Eastern Michigan University and Pfizer Global Research and Development present “Trends in Alzheimer’s Testing and Ethical Implications,” Thursday, March 23, 7 p.m., at EMU’s Halle Library Auditorium in Ypsilanti. The lecture is free and open to the public.
Guest speakers are psychologist Renee Lajiness-O’Neil, Ph.D., and Jill Dieterle, Ph.D., an expert in medical ethics.
Alzheimer’s disease, the most common form of dementia in persons over 65, is a brain disorder that gradually destroys a person’s memory and ability to learn, reason, make judgments and carry out daily activities. There currently is no cure for the disease.
“Currently, the diagnosis for Alzheimer’s is based on cognitive testing. It can be a murky diagnosis. As a result, you have to gather as much data as possible to make an informed diagnosis,” said Lajiness-O’Neil, assistant professor of psychology at EMU.
“This program is designed to educate the community on how testing can help determine a person’s strengths and weakness; what can be done on a long-term basis; what a person can expect in the long run; and how to effectively manage Alzheimer’s.”
For more information on the seminar, call 734.487.1361.
Eastern Michigan University is a public, comprehensive university that offers programs in the arts, sciences and professions. EMU prepares students with the intellectual skills and practical experiences to succeed in their careers and lives, and to be better citizens.
Eastern Michigan University is a public, comprehensive university that offers programs in the arts, sciences and professions. EMU prepares students with the intellectual skills and practical experiences to succeed in their career and lives, and to be better citizens.
Editor's Note: Looking for an expert source for a story? Check out EMU's Eastern Experts online at www.emich.edu/univcomm/easternexperts.